VaxInnate Receives $2.1 million from New Jersey’s Technology Business Tax Certificate Transfer Program EDA LogoCRANBURY, NJ, January 28, 2014 – VaxInnate Corporation, a biotechnology firm pioneering a breakthrough technology platform for the development of novel...
Concert Pharmaceuticals Announces Pricing of Initial Public Offering LEXINGTON, Mass.– Feb 13, 2014 –Concert Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at a public offering price...
Awarepoint Drives Growth and Moves Client Base to Next Generation Platform Healthcare RTLS leader reports significant movement in client base toward next generation platform, continued growth SAN DIEGO – February 13, 2014 – Awarepoint Corporation, the largest...
Versartis Secures $55 Million in Series E Financing REDWOOD CITY, CA – Feb 18, 2014 – Versartis, Inc., an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human growth hormone (rhGH) for the treatment...
Optum Acquires Majority Interest in Audax Health Solutions Optum’s investment seeks to expand the breadth and reach of Audax’s multichannel digital platform, providing greater resources for consumers to better manage their health MINNEAPOLIS – (Feb. 19, 2014) – Optum...
Intarcia Appoints Jay Smith Head of Customer Experience & Outcomes Smith takes-on innovative CXO role to optimize customer experiences and consistently deliver the best possible outcomes for patients, payors and providers BOSTON, MA – February 26, 2014 – Intarcia...
Recent Comments